What Aristo Pharma does

Aristo Pharma GmbH is a privately held German pharmaceutical manufacturer founded in 2008 and headquartered in Berlin. The company produces high-quality, cost-effective generic medicines supplemented by in-house developed formulations and over-the-counter (OTC) products, with the majority of manufacturing conducted at five proprietary production sites in Germany and Spain and supported by an in-house logistics center. Its portfolio spans more than 30 branded products across major therapeutic areas including pain management (Fentanyl Aristo®, FentAristo®), neurology (Quetiapin Aristo®, Rivastigmin Aristo®, Natriumoxybat Aristo®, Tranylcypromine Aristo), cardiovascular and anticoagulation (Rivaroxaban Aristo®, Dronedaron Aristo®), infectious disease (Voriconazol Aristo®, Brivudin Aristo®, Tenofovirdisoproxil Aristo®), rheumatology (Leflunomid Aristo®), psychiatry, gynecology and hormonal contraceptives (Cedia®, Lilia®, Xellia®, FemLoop® Vaginalring, Arifem® hydro 2in1), as well as OTC and herbal lines (Cetirizin Aristo®, Sedariston®, Solidago Steiner®, Tonsino®).

The company distributes prescription and OTC products primarily through pharmacy networks in Germany and Austria, with direct hospital and clinical supply for specialty products requiring professional handling, and operates regional entities in Spain (Aristo Pharma Iberia) and Austria (Aristo Pharma Österreich). Aristo Pharma engages healthcare professionals via a DocCheck-authenticated specialist portal (Fachbereich) providing training, CME courses, and product information, and targets end-consumers with health-guide content covering respiratory, cardiovascular, gastrointestinal, and other conditions. The business model is sales-led across multiple channels — field sales, internal sales organization, and pharmacy distribution — generating revenue primarily through one-time product sales under regulated German reference pricing.

With 1,750+ group employees, the company has been recognized by IQVIA PharmaScope as a Top 10 supply-strongest pharmaceutical manufacturer in Germany by sales volume (daily defined doses, January-September 2021) and holds EN ISO 50001 energy management certification. Recent strategic activity has centered on portfolio expansion through specialty Rx launches (notably Rivaroxaban and Fentanyl buccal formulations in 2025), geographic extension into the Netherlands, and a December 2023 capital participation in VaRi Bioscience to access long-acting vaginal ring drug-delivery technology.

Name

Aristo Pharma

Legal name

Aristo Pharma GmbH

Website

https://aristo-pharma.de

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Aristo Pharma is a privately held German pharmaceutical manufacturer producing generic, specialty, and OTC medicines across 30+ branded products via five production sites in Germany and Spain, distributing primarily through pharmacies in Germany, Austria, Spain, and the Netherlands.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541), Medicinal and Botanical Manufacturing (325411)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic Hospital & Institutional Products (HLAIABAL)

akta.pro secondary industries

Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health) (HLAIAAAJ), Pain Management & Anesthesiology Pharmaceuticals (HLAIAAAN), Respiratory & Allergy Pharmaceuticals (HLAIAAAH), OTC Medicines & Consumer Health Products Distribution (CRAOAHAB)

Keywords

• Generic pharmaceuticals
• Prescription medicines
• Over-the-counter products
• Pharmaceutical manufacturing
• Drug formulation

Headquarters

HQ city

Berlin

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Prescription Generic Medicines: Generic versions of original pharmaceutical products sold through pharmacies with prescriptions. The majority of products are produced at company's own production sites in Germany and Spain.
2. Over-the-Counter (OTC) Products: Non-prescription pharmaceutical products sold directly through pharmacies to consumers.
3. In-house Developed Products: Proprietary product formulations developed internally, complementing the generic portfolio.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

Aristo Pharma manufactures and distributes a broad portfolio of generic pharmaceutical products, supplemented by in-house developed formulations and over-the-counter (OTC) medicines. The vast majority of products are produced at the company's own five production sites in Germany and Spain, covering therapeutic areas such as pain management, neurology, cardiovascular, gynecology, HIV/HBV, and respiratory conditions.

Product overview

Aristo Pharma is a German pharmaceutical company founded in 2008 that produces generic medicines, in-house developments, and over-the-counter (OTC) products. The company operates five production sites in Germany and Spain and employs more than 1,750 people. Their product portfolio includes: (1) Generic prescription pharmaceuticals across therapeutic areas including analgesics (Fentanyl Aristo®, FentAristo®), neurological treatments (Rivastigmin Aristo®, Natriumoxybat Aristo®, Quetiapin Aristo®, Tranylcypromine Aristo®), cardiovascular/anticoagulants (Rivaroxaban Aristo®, Dronedaron Aristo®), anti-epileptics (Valproat Aristo®), antifungals (Voriconazol Aristo®), immunosuppressants (Leflunomid Aristo®), antivirals (Brivudin Aristo®, Tenofovirdisoproxil Aristo®), and hormonal contraceptives (Cedia®, Lilia®, Xellia®, Jennifer® 35, Amicette®, Aristelle®, VeRi, FemLoop® Vaginalring); (2) OTC/allergy products (Cetirizin Aristo® Allergiesaft); (3) Herbal products (Solidago Steiner®); (4) Specialty products (Sedariston® drops/night drops/concentrate, Arifem® hydro 2in1 Vaginalgel, Tonsino® throat spray/solution); and (5) Health information services covering respiratory diseases, depression, gastrointestinal conditions, and other health topics. The majority of products are produced at the company's own facilities in Germany and Spain, with a focus on making high-quality medicines affordable and accessible.

Differentiator

Problem solved

Functional benefit

Brands

• Aristo Pharma: Main corporate brand for pharmaceutical products including prescription medicines, generics, and OTC products.
• Aristo Pharma Iberia
• Aristo Pharma Österreich
• Pharma Wernigerode

Products and services

• Arifem® hydro 2in1 Vaginalgel Vaginal gel product for gynecological applications with a 2in1 dual-action formulation.
• Tonsino® for sore throats Gargle solution and spray containing benzydaminehydrochlorid (1.5 mg/ml) for symptomatic treatment of pain and irritation in the mouth and throat.
• Cetirizin Aristo® Allergiesaft Allergy solution/syrup (OTC) for the treatment of allergic symptoms.
• Solidago Steiner® Tabletten Herbal tablet formulation.
• Sedariston® Tropfen für die Nacht Night-time drops for sleep support.
• Sedariston® Konzentrat Concentrate formulation in hard gelatin capsules.
• Sedariston® Tropfen Drops formulation for flexible dosing.
• Fentanyl Aristo® Opioid analgesic available as buccal tablets in multiple dosages (100, 200, 400, 600, 800 µg) for pain management.
• FentAristo® Buccalfilm Fentanyl buccal film formulation for transmucosal drug delivery in pain treatment.
• Rivastigmin Aristo® Transdermal patch (24-hour) for dementia treatment, available in 4.6 mg and 9.5 mg strengths.
• Natriumoxybat Aristo® Sodium oxybate product for narcolepsy treatment with patient card, dosing instructions, FAQ, and pediatric patient guide.
• Rivaroxaban Aristo® Anticoagulant/NOAC (Non-vitamin K antagonist oral anticoagulant) for prevention and treatment of blood clots.
• Valproat Aristo® Anti-epileptic drug available as 300 mg and 600 mg enteric-coated film-coated tablets and oral drops solution.
• Voriconazol Aristo® Antifungal medication available in 50 mg, 100 mg, and 200 mg film-coated tablets.
• Quetiapin Aristo® Atypical antipsychotic for treatment of schizophrenia and bipolar disorder.
• Leflunomid Aristo® Disease-modifying antirheumatic drug (DMARD) available in 10 mg and 20 mg film-coated tablets.
• Dronedaron Aristo® Antiarrhythmic medication (400 mg film-coated tablets) for rhythm control in atrial fibrillation.
• Brivudin Aristo® Antiviral medication for herpes zoster (shingles) treatment.
• Tenofovirdisoproxil Aristo® Antiviral medication (245 mg film-coated tablets) for HIV and HBV treatment.
• Cedia® Combined hormonal contraceptive available as Cedia® 20 (20 µg/150 µg tablets) and Cedia® 30 (30 µg/150 µg tablets).
• Lilia® Combined hormonal contraceptive film-coated tablets (0.03 mg/2 mg).
• Xellia® Combined hormonal contraceptive available as Xellia® 20 (0.02 mg/3 mg film-coated tablets) and Xellia® 30 (0.03 mg/3 mg film-coated tablets).
• Jennifer® 35 Combined hormonal contraceptive film-coated tablets (2 mg/0.035 mg) with anti-androgenic properties.
• Aristelle® Combined hormonal contraceptive film-coated tablets (0.03 mg/2 mg).
• FemLoop® Vaginalring Combined hormonal contraceptive vaginal ring for birth control.
• Lisdex Aristo® ADHD medication (Lisdexamfetamine) with application checklist for patients.
• L-Thyroxin Aristo® Thyroid hormone replacement medication for hypothyroidism treatment.
• Tranylcypromine Aristo Monoamine oxidase inhibitor (MAOI) antidepressant with patient card and patient booklet for depression treatment.

Named customers2 records

Segments3 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

13 partnerships are on record, tiered core and minor.

• VaRi BiosciencecoreStrategic or Co-development Partner · 12 December 2023Aristo Pharma entered into a capital participation agreement with VaRi Bioscience, becoming a shareholder. VaRi Bioscience will continue developing its pipeline of long-acting vaginal rings, with focus on the main product VR102.
• primus consulting group GmbHminorOthersAristo Pharma partners with primus consulting group GmbH for their whistleblower system. The firm handles reporting of compliance-relevant violations and misconduct, providing hotline and email reporting channels.
• DocCheck Medical Services GmbHcoreTechnology or IntegrationDocCheck provides authentication services for the specialist portal (Fachbereich). Healthcare professionals must authenticate via DocCheck systems to access exclusive content, training materials, and product information.
• Apotheker ohne Grenzen e.V.minorGTM or Marketing PartnerAristo Pharma supports the pharmaceutical aid organization Apotheker ohne Grenzen, which provides humanitarian pharmaceutical assistance in Germany and worldwide. The company has been cooperating with this organization for 8 years (as of 2025), supporting sustainable improvement of health structures and rapid pharmaceutical emergency aid after disasters.
• Caritas Berlin (Caritas-Arztmobil)minorGTM or Marketing PartnerAristo Pharma supports the Caritas medical van service in Berlin with annual donations of 10,000 euros since 2016, providing medical care for homeless people at locations including overnight shelters, soup kitchens, warming stations, and train stations.
• Caritas Wien (Louisebus)minorGTM or Marketing PartnerAristo Pharma Austria supports the Louisebus of Caritas Vienna, providing free medical care to people without health insurance. Donation of 10,000 euros.
• Deutsche Schmerzliga e.V.minorGTM or Marketing PartnerAristo Pharma became a supporting member of the German Pain League, supporting the organization's mission to improve the situation of pain sufferers for over 28 years.
• World Doctors Orchestra e.V.minorGTM or Marketing PartnerAristo Pharma is an official sponsor of the World Doctors Orchestra, which combines musical excellence with global medical responsibility through benefit concerts supporting medical aid projects.
• DKMS (Deutsche Knochenmarkspenderdatei)minorGTM or Marketing PartnerAristo Pharma supports the German Bone Marrow Donor Centre through donations, helping expand the donor registry for blood cancer patients.
• Freundeskreis der Charité e.V.minorGTM or Marketing PartnerAristo Pharma donated 5,000 euros to the Friends of Charité association, supporting selected projects like a mentoring program for aspiring nursing leaders and promoting exchange between the hospital and society.
• Herzenswünsche e.V.minorGTM or Marketing PartnerAristo Pharma supports the Herzenswünsche charity through their 'Spenden statt Schenken' (Donate instead of gifts) winter campaign, helping fulfill dreams of seriously ill children.
• ROTE NASEN Deutschland e.V.minorGTM or Marketing PartnerAristo Pharma continues its engagement with ROTE NASEN (Red Noses) Germany, a charity that brings humor and moments of lightness to people in need through clown visits.
• Berliner Stadtmission (Kältebus)minorGTM or Marketing PartnerAristo Pharma supports the cold weather bus service of Berlin City Mission, providing assistance to homeless people during winter months.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• Glenmark Pharmaceuticals: India-headquartered generic and specialty pharma group with growing European generics business. Comparable on generic Rx manufacturing and emerging European footprint, though with different geographic mix and therapeutic emphasis.

Direct peers

• Heumann Pharma: German generic pharmaceutical company offering Rx and OTC products through pharmacy distribution, now part of the Stada group. Closely comparable to Aristo in German generic Rx/OTC portfolio construction.
• Dermapharm Holding: German vertically integrated pharma manufacturer with own production, focus on generics, OTC and dermatology products distributed through pharmacies. Comparable on German manufacturing footprint and pharmacy-channel generics model.
• Stada Arzneimittel: Privately owned German generics and specialty pharma group with own manufacturing and pharmacy-channel distribution across DACH. Closest peer to Aristo on integrated generics + OTC model and European footprint.
• Hexal: German generics subsidiary of Sandoz (Novartis), one of the largest suppliers of generic medicines to German pharmacies. Directly comparable on Rx generics portfolio, therapeutic-area breadth, and German pharmacy distribution.
• Ratiopharm: Germany's largest generic pharmaceutical brand, wholly owned by Teva, distributing a broad Rx and OTC portfolio through German pharmacies. Directly comparable to Aristo Pharma on product mix, channel (pharmacy), and therapeutic-area breadth in the German market.

Broad incumbents

• Sandoz (Novartis): Global generics and biosimilars leader spun out of Novartis, with strong German operations through Hexal. Comparable on generic Rx portfolio, but with substantially larger scale, biosimilars exposure, and global reach.
• Teva Pharmaceutical Industries: World's largest generic drug manufacturer with extensive German footprint via Ratiopharm. Comparable on Rx generics and OTC categories, but operates at much greater scale and with global API and biosimilars capabilities.
• Viatris: Global generics and specialty pharma company formed from Mylan and Upjohn, with established European presence. Comparable on Rx generics portfolio across therapeutic areas, though materially larger and more diversified than Aristo.
• Aurobindo Pharma: India-headquartered global generic manufacturer with significant European and German-market presence through subsidiary Aurobindo Pharma GmbH. Comparable on broad generic Rx portfolio and pharmacy-channel supply, but with much larger scale and global API integration.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aristo Pharma